ODIG-Dun and Bradstreet Contract

Justification: Without the continuation of this data access, there will be catastrophic impacts to FDA business operations, public health, and regulatory mission, prohibiting capabilities to support inspections and respond to crisis. This will impact the FDA's 44+ Submission, Registration and Listing (SRL) systems that are used by 10 centers,10,000 FDA users and Industry to validate and verify company information submitted to the FDA. Beyond thedisruption to systems, data quality would be at risk. Such a disruption of FDA businesses, as well as vitaloperational and technical services, would negatively impact the agency's ability to protect against cyber threats,i.e. detecting against falsified data under a company's name, protecting access to confidential regulatorinformation, and protecting against the theft of confidential manufacturing information submitted to FDA. Afailure to properly validate information received by the Agency may result in taking incorrect or inappropriateactions based on the wrong information, that can lead to damage to FDA reputation, legal liability and releaseunsafe and defective products to American public. The threats, vulnerabilities, and risks to our critical assetsremain high and pose significant risk to our internet facing assets, industry partners, public health mission andreputation as a world health leader.

Estimated value

>= $3M and < $7M

Est. solicitation date

Jun 1, 2026

Anticipated award

Dec 1, 2026